Home › Glomerulonephritis
Pag-aaral pangklinika para sa Glomerulonephritis na nagre-recruit sa U.S.
9 pag-aaral para sa Glomerulonephritis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07431931Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Nagre-recruitPhase 3
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07498335A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07902817A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07541287A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04557462PS-002 for the Treatment of IgA Nephropathy in Adults
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07182227Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06858319Atacicept in Multiple Glomerular Diseases
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06983028Study of BHV-1400 in IgA Nephropathy
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07054684Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.